Form 4 for RGNX REGENXBIO Inc.
Accepted 2023-06-06 00:00:00 ET · period of report 2023-06-02 · accession 0001562180-23-004896 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-06 | 2023-06-02 | RGNX | Fox Allan M. | Dir | A - Grant | $0.00 | +3,486 | 6,496 | +116% | $0 |
| D | 2023-06-06 | 2023-06-02 | RGNX | Fox Allan M. | Dir | A - Grant | $0.00 | +17.9K | 17.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-02 | A | A | 3,486 | $0.00 | 6,496 | D | — | — | (F1) Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer. |
| 2 | Derivative | Stock Options (Right to Buy) | 2023-06-02 | A | A | 17,892 | $0.00 | 17,892 | D | $19.72 · — to 2033-06-02 | 17,892 Common Stock | (F3) The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer. |